Kerin B. Adelson

2.5k total citations · 1 hit paper
86 papers, 1.6k citations indexed

About

Kerin B. Adelson is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Economics and Econometrics. According to data from OpenAlex, Kerin B. Adelson has authored 86 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Public Health, Environmental and Occupational Health, 36 papers in Oncology and 26 papers in Economics and Econometrics. Recurrent topics in Kerin B. Adelson's work include Palliative Care and End-of-Life Issues (35 papers), Economic and Financial Impacts of Cancer (24 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Kerin B. Adelson is often cited by papers focused on Palliative Care and End-of-Life Issues (35 papers), Economic and Financial Impacts of Cancer (24 papers) and Health Systems, Economic Evaluations, Quality of Life (14 papers). Kerin B. Adelson collaborates with scholars based in United States, Canada and Israel. Kerin B. Adelson's co-authors include Cary P. Gross, M. Elizabeth Paulk, Alfred I. Neugut, Manish A. Shah, Yuhua Bao, Paul K. Maciejewski, Holly G. Prigerson, Bryan J. Schneider, M. Carrington Reid and Melissa M. Garrido and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Kerin B. Adelson

83 papers receiving 1.6k citations

Hit Papers

Chemotherapy Use, Performance Status, and Quality of Life... 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life
    2015 422 citations Kerin B. Adelson et al. JAMA Oncology profile →

Peers

Kerin B. Adelson
Michael N. Neuss United States
Janette K. Merrill United States
Andrea Denicoff United States
Theresa Shao United States
Michael Montello United States
Kristen K. McNiff United States
Lynn Ries United States
Nicole Mittmann Canada
Gabriel A. Brooks United States
Carolyn J. Presley United States
Michael N. Neuss United States
Kerin B. Adelson
Citations per year, relative to Kerin B. Adelson Kerin B. Adelson (= 1×) peers Michael N. Neuss

Countries citing papers authored by Kerin B. Adelson

Since Specialization
Citations

This map shows the geographic impact of Kerin B. Adelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerin B. Adelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerin B. Adelson more than expected).

Fields of papers citing papers by Kerin B. Adelson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerin B. Adelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerin B. Adelson. The network helps show where Kerin B. Adelson may publish in the future.

Co-authorship network of co-authors of Kerin B. Adelson

This figure shows the co-authorship network connecting the top 25 collaborators of Kerin B. Adelson. A scholar is included among the top collaborators of Kerin B. Adelson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerin B. Adelson. Kerin B. Adelson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Yang, Maureen Canavan, Nina Kim, et al.. (2024). Prognostic Understanding, Goals of Care, and Quality of Life in Hospitalized Patients with Leukemia or Multiple Myeloma. Journal of Palliative Medicine. 27(7). 879–887. 1 indexed citations
3.
4.
Canavan, Maureen, Xiaoliang Wang, Mustafa Ascha, et al.. (2024). Systemic Anticancer Therapy and Overall Survival in Patients With Very Advanced Solid Tumors. JAMA Oncology. 10(7). 887–887. 12 indexed citations
5.
Davies, Marianne, et al.. (2024). A Qualitative Study on the Impact and Feasibility of a Simulation-Based Program for Shared Decision-Making in Non–Small Cell Lung Cancer Care. The Permanente Journal. 28(3). 212–222. 3 indexed citations
6.
Adelson, Kerin B., Maureen Canavan, Jiangong Niu, et al.. (2024). Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis.. JCO Oncology Practice. 20(10_suppl). 276–276. 1 indexed citations
7.
Rothberg, Bonnie E. Gould, et al.. (2023). Outcomes on an inpatient oncology service after the introduction of hospitalist comanagement. Journal of Hospital Medicine. 18(5). 391–397. 5 indexed citations
8.
Pršić, Elizabeth, et al.. (2023). Oncology hospitalist impact on hospice utilization. Cancer. 129(23). 3797–3804.
9.
Foldi, Julia, Andrea Silber, Tao Qing, et al.. (2022). Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC. Clinical Cancer Research. 28(17). 3720–3728. 13 indexed citations
10.
Chen, Kevin, et al.. (2022). Self-Reported COVID-19 Infections and Social Mixing Behavior at Oncology Meetings. International Journal of Radiation Oncology*Biology*Physics. 114(1). 30–38. 2 indexed citations
11.
Zoň, Robin, Erin B. Kennedy, Kerin B. Adelson, et al.. (2021). Telehealth in Oncology: ASCO Standards and Practice Recommendations. JCO Oncology Practice. 17(9). 546–564. 92 indexed citations
12.
Kennedy, Erin B., Kerin B. Adelson, R.R. Brodie, et al.. (2021). Oncology Medical Home: ASCO and COA Standards. JCO Oncology Practice. 17(8). 475–492. 21 indexed citations
13.
Yardley, Denise A., Robyn R. Young, Kerin B. Adelson, et al.. (2021). A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC). Clinical Breast Cancer. 22(3). 269–278. 9 indexed citations
14.
Kunst, Natalia, Shi‐Yi Wang, Sarah S. Mougalian, et al.. (2020). Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women WithERBB2(HER2)–Positive Breast Cancer. JAMA Network Open. 3(11). e2027074–e2027074. 14 indexed citations
15.
Smith, Cardinale B., et al.. (2018). Goals of Care Conversations in Advanced Cancer: Patient Perceptions Versus Reality (FR419B). Journal of Pain and Symptom Management. 55(2). 604–605. 3 indexed citations
16.
Kenny, Timothy C., Hank Schmidt, Kerin B. Adelson, et al.. (2017). Patient-derived Interstitial Fluids and Predisposition to Aggressive Sporadic Breast Cancer through Collagen Remodeling and Inactivation of p53. Clinical Cancer Research. 23(18). 5446–5459. 17 indexed citations
17.
Smith, Cardinale B., et al.. (2017). Speaking Up: How Patient and Physician Voices Shaped a Trial to Improve Goals-of-Care Discussions. Patient. 10(4). 489–501. 9 indexed citations
18.
Wang, Shi‐Yi, Jane Hall, Craig Evan Pollack, et al.. (2016). Trends in end-of-life cancer care in the Medicare program. Journal of Geriatric Oncology. 7(2). 116–125. 63 indexed citations
19.
Abu‐Khalaf, Maysa, Sarah S. Mougalian, Tara Sanft, et al.. (2015). A phase II trial of neoadjuvant aromatase inhibitor therapy and the mTOR inhibitor everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancer and a low/intermediate risk Oncotype Dx Recurrence Score (≤ 25).. Journal of Clinical Oncology. 1 indexed citations
20.
Adelson, Kerin B., Doris Germain, George Raptis, & Noa Biran. (2011). Hormonal Modulation in the Treatment of Breast Cancer. Endocrinology and Metabolism Clinics of North America. 40(3). 519–532. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael N. Neuss Breakdown of academic impact, for papers by Janette K. Merrill Breakdown of academic impact, for papers by Andrea Denicoff Breakdown of academic impact, for papers by Theresa Shao Breakdown of academic impact, for papers by Michael Montello Breakdown of academic impact, for papers by Kristen K. McNiff Breakdown of academic impact, for papers by Lynn Ries Breakdown of academic impact, for papers by Nicole Mittmann Breakdown of academic impact, for papers by Gabriel A. Brooks Breakdown of academic impact, for papers by Carolyn J. Presley
Rankless by CCL
2026